PRVCF (PreveCeutical Medical) Other Income (Expense): $1.44 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PreveCeutical Medical Other Income (Expense)?

PreveCeutical Medical PRVCF -4.69% Other Income (Expense) is $1.44 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

PreveCeutical Medical's other income expense for the PreveCeutical Medical's pretax income for the three months ended in Dec. 2025 was $1.44 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2025 was $1.44 Mil.

PreveCeutical Medical  (OTCPK:PRVCF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

PreveCeutical Medical Other Income (Expense) Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical Other Income (Expense) Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.30 -0.14 -0.00 -0.03 1.44

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 0.02 -0.00 1.44

PreveCeutical Medical Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Income (Expense) →
What does a Other Income (Expense) of $1.44 Mil mean?
PreveCeutical Medical (PRVCF) has a Other Income (Expense) of $1.44 Mil as of Dec. 2025. Other income and expenses that a company records on the income statement. View historical data on PreveCeutical Medical and its competitors.
Is PreveCeutical Medical's Other Income (Expense) too high?
PreveCeutical Medical's current Other Income (Expense) is $1.44 Mil.
How does PreveCeutical Medical's Other Income (Expense) compare to VRTX and REGN?
PreveCeutical Medical's Other Income (Expense) of $1.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Income (Expense) for a Biotechnology company?
A good Other Income (Expense) depends on the Biotechnology industry context. However, Other Income (Expense) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Income (Expense) mean?
A high Other Income (Expense) can signal that a stock is expensive relative to its fundamentals. Other income and expenses that a company records on the income statement. View historical data on PreveCeutical Medical and its competitors. PreveCeutical Medical's current Other Income (Expense) is $1.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (PRVCF) has a current Other Income (Expense) of $1.44 Mil. The current Other Income (Expense) is $1.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Income (Expense) calculated?
Other Income (Expense) is calculated from a company's financial statements. For PreveCeutical Medical (PRVCF), the current Other Income (Expense) is $1.44 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges 18H0:GermanyPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.